{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:14:17Z","timestamp":1789596857527,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.chest.2019.01.034","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T08:56:10Z","timestamp":1556873770000},"page":"e117-e121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease"],"prefix":"10.1016","volume":"155","author":[{"given":"Julie","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Hunninghake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane R.","family":"Wesemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2019.01.034_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clim.2009.10.002","article-title":"Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"134","author":"Park","year":"2010","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.chest.2019.01.034_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.01.034_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"4","key":"10.1016\/j.chest.2019.01.034_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.iac.2012.08.003","article-title":"Granulomatous lymphocytic interstitial lung disease","volume":"32","author":"Fern\u00e1ndez P\u00e9rez","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.chest.2019.01.034_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaci.2013.08.022","article-title":"Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency","volume":"133","author":"Maglione","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.chest.2019.01.034_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2016.00258","article-title":"Inducible bronchus-associated lymphoid tissue: taming inflammation in the lung","volume":"7","author":"Hwang","year":"2016","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.chest.2019.01.034_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/imm.12649","article-title":"The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation","volume":"149","author":"Yadava","year":"2016","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.chest.2019.01.034_bib8","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1172\/JCI28756","article-title":"Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis","volume":"116","author":"Rangel-Moreno","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.chest.2019.01.034_bib9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3389\/fimmu.2017.01639","article-title":"Spoiling for a fight: B lymphocytes as initiator and effector populations within tertiary lymphoid organs in autoimmunity and transplantation","volume":"8","author":"Alsughayyir","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.01.034_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1096\/fj.11-186973","article-title":"Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses","volume":"26","author":"Motallebzadeh","year":"2012","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.chest.2019.01.034_bib11","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.4049\/jimmunol.174.9.5720","article-title":"Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles","volume":"174","author":"McDonald","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.chest.2019.01.034_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.it.2015.05.005","article-title":"T\u00a0follicular regulatory cells in the regulation of B cell responses","volume":"36","author":"Sage","year":"2015","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.chest.2019.01.034_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCULATIONAHA.114.010988","article-title":"Control of the T follicular helper-germinal center B-cell axis by CD8+ regulatory T\u00a0cells limits atherosclerosis and tertiary lymphoid organ development","volume":"131","author":"Clement","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.chest.2019.01.034_bib14","first-page":"1077","article-title":"Rituximab therapy in primary Sj\u00f6gren\u2019s syndrome with interstitial lung disease: a retrospective cohort study","volume":"34","author":"Chen","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.chest.2019.01.034_bib15","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","article-title":"Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years\u2019 experience at a single centre","volume":"56","author":"Md Yusof MY","year":"2017","journal-title":"Rheumatology"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219301990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219301990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:08:27Z","timestamp":1757923707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219301990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0012369219301990"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2019.01.034","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2019.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}